Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France)-Reference-Cited by-同舟云学术

Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France)

Published:2020-12-01 Issue:6 Volume:18 Page:517-524
ISSN:1947-5535
Container-title:Biopreservation and Biobanking
language:en
Short-container-title:Biopreservation and Biobanking

Author:

Tanga Virginie¹²,Leroy Sylvie³,Fayada Julien¹,Hamila Marame¹,Allegra Maryline¹,Messaoudi Zeineb¹,Bonnetaud Christelle¹,Lespinet Virgine¹,Bordone Olivier¹,Washetine Kevin¹,Griffonnet Jennifer³,Maniel Charlotte³,Philibert Lorène³,Selva Eric¹,Benzaquen Jonathan³,Ilie Marius¹²,Long Elodie¹²,Lassalle Sandra¹²,Lantéri Elisabeth¹²,Marquette Charles-Hugo²³,Hofman Véronique¹²,Hofman Paul¹²

Affiliation:

1. Laboratory of Clinical and Experimental Pathology (LPCE), Biobank (BB-0033-00025), FHU-OncoAge, Nice Hospital University, Université Côte d'Azur, Nice, France.

2. IRCAN, CNRS, INSERM, Centre Antoine Lacassagne, FHU-OncoAge, Université Côte d'Azur, Nice, France.

3. Department of Pneumology, FHU-OncoAge, Nice Hospital University, Université Côte d'Azur, Nice, France.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,General Biochemistry, Genetics and Molecular Biology,General Medicine,Medicine (miscellaneous)

Link

https://www.liebertpub.com/doi/pdf/10.1089/bio.2020.0055

Reference43 articles.

1. COVID-19 needs a big science approach

2. Rapid COVID-19 vaccine development

3. A Review of SARS-CoV-2 and the Ongoing Clinical Trials